Publicaciones (33) Publicaciones de Oihana Murillo Sauca

2024

  1. Profile of plasma microRNAs as a potential biomarker of Wilson’s disease

    Journal of Gastroenterology, Vol. 59, Núm. 10, pp. 921-931

2022

  1. High value of 64Cu as a tool to evaluate the restoration of physiological copper excretion after gene therapy in Wilson's disease

    Molecular Therapy - Methods and Clinical Development, Vol. 26, pp. 98-106

2019

  1. Liver Expression of a MiniATP7B Gene Results in Long-Term Restoration of Copper Homeostasis in a Wilson Disease Model in Mice

    Hepatology, Vol. 70, Núm. 1, pp. 108-126

2018

  1. Brain copper storage after genetic long-term correction in a mouse model of Wilson disease

    Neurology: Genetics, Vol. 4, Núm. 3

  2. CD271 confers an invasive and metastatic phenotype of head and neck squamous cell carcinoma through the upregulation of slug

    Clinical Cancer Research, Vol. 24, Núm. 3, pp. 674-683

  3. Visualization of the therapeutic efficacy of a gene correction approach in Wilson's disease by laser-ablation inductively coupled mass spectrometry

    Journal of Hepatology

2016

  1. Long-term metabolic correction of Wilson's disease in a murine model by gene therapy

    Journal of Hepatology, Vol. 64, Núm. 2, pp. 419-426

2014

  1. CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma

    Oncotarget, Vol. 5, Núm. 16, pp. 6854-6866

2013

  1. Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Núm. 30, pp. 12391-12396

  2. T cell costimulation with anti-CD137 monoclonal antibodies is mediated by K63-polyubiquitin-dependent signals from endosomes

    Journal of Immunology, Vol. 190, Núm. 12, pp. 6694-6706

2012

  1. CD137 on inflamed lymphatic endothelial cells enhances CCL21-guided migration of dendritic cells

    FASEB Journal, Vol. 26, Núm. 8, pp. 3380-3392

  2. CD44+ cells have cancer stem cell-like properties in nasopharyngeal carcinoma

    International Forum of Allergy and Rhinology, Vol. 2, Núm. 6, pp. 465-470

  3. ERK1/2 regulation of CD44 modulates oral cancer aggressiveness

    Cancer Research, Vol. 72, Núm. 1, pp. 365-374

  4. Liver Gene Transfer of Interkeukin-15 Constructs That Become Part of Circulating High Density Lipoproteins for Immunotherapy

    PLoS ONE, Vol. 7, Núm. 12

  5. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 109, Núm. 17, pp. 6662-6667

2010

  1. Proliferating NK cells in response to IL-15 do not upregulate surface B220 in vivo

    Gene Therapy

2009

  1. In vivo depletion of DC impairs the anti-tumor effect of agonistic anti-CD137 mAb

    European Journal of Immunology, Vol. 39, Núm. 9, pp. 2424-2436

2008

  1. Interleukin-15 liver gene transfer increases the number and function of IKDCs and NK cells

    Gene Therapy, Vol. 15, Núm. 7, pp. 473-483

  2. Multi-layered action mechanisms of CD137 (4-1BB)-targeted immunotherapies

    Trends in Pharmacological Sciences, Vol. 29, Núm. 8, pp. 383-390

  3. Therapeutic antitumor efficacy of anti-CD137 agonistic monoclonal antibody in mouse models of myeloma

    Clinical Cancer Research, Vol. 14, Núm. 21, pp. 6895-6906